메뉴 건너뛰기




Volumn 60, Issue 4, 2015, Pages 547-560

Targeting the DNA Damage Response in Cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN E; DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OLAPARIB;

EID: 84947751230     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2015.10.040     Document Type: Review
Times cited : (1123)

References (123)
  • 5
    • 49249119415 scopus 로고    scopus 로고
    • A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair
    • Ashworth A. A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. J. Clin. Oncol. 2008, 26:3785-3790.
    • (2008) J. Clin. Oncol. , vol.26 , pp. 3785-3790
    • Ashworth, A.1
  • 6
    • 84872044020 scopus 로고    scopus 로고
    • The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective
    • Ataman O.U., Sambrook S.J., Wilks C., Lloyd A., Taylor A.E., Wedge S.R. The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective. Int. J. Radiat. Oncol. Biol. Phys. 2012, 84:e447-e454.
    • (2012) Int. J. Radiat. Oncol. Biol. Phys. , vol.84 , pp. e447-e454
    • Ataman, O.U.1    Sambrook, S.J.2    Wilks, C.3    Lloyd, A.4    Taylor, A.E.5    Wedge, S.R.6
  • 7
    • 77955039099 scopus 로고    scopus 로고
    • Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
    • Audeh M.W., Carmichael J., Penson R.T., Friedlander M., Powell B., Bell-McGuinn K.M., Scott C., Weitzel J.N., Oaknin A., Loman N., et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet 2010, 376:245-251.
    • (2010) Lancet , vol.376 , pp. 245-251
    • Audeh, M.W.1    Carmichael, J.2    Penson, R.T.3    Friedlander, M.4    Powell, B.5    Bell-McGuinn, K.M.6    Scott, C.7    Weitzel, J.N.8    Oaknin, A.9    Loman, N.10
  • 8
    • 18244385718 scopus 로고    scopus 로고
    • ATRIP binding to replication protein A-single-stranded DNA promotes ATR-ATRIP localization but is dispensable for Chk1 phosphorylation
    • Ball H.L., Myers J.S., Cortez D. ATRIP binding to replication protein A-single-stranded DNA promotes ATR-ATRIP localization but is dispensable for Chk1 phosphorylation. Mol. Biol. Cell 2005, 16:2372-2381.
    • (2005) Mol. Biol. Cell , vol.16 , pp. 2372-2381
    • Ball, H.L.1    Myers, J.S.2    Cortez, D.3
  • 9
    • 84947795362 scopus 로고    scopus 로고
    • Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer
    • Published online August 17, 2015
    • Bang Y.J., Im S.A., Lee K.W., Cho J.Y., Song E.K., Lee K.H., Kim Y.H., Park J.O., Chun H.G., Zang D.Y., et al. Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer. J. Clin. Oncol. 2015, Published online August 17, 2015.
    • (2015) J. Clin. Oncol.
    • Bang, Y.J.1    Im, S.A.2    Lee, K.W.3    Cho, J.Y.4    Song, E.K.5    Lee, K.H.6    Kim, Y.H.7    Park, J.O.8    Chun, H.G.9    Zang, D.Y.10
  • 10
    • 84875018599 scopus 로고    scopus 로고
    • Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma
    • Barazzuol L., Jena R., Burnet N.G., Meira L.B., Jeynes J.C., Kirkby K.J., Kirkby N.F. Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma. Radiat. Oncol. 2013, 8:65.
    • (2013) Radiat. Oncol. , vol.8 , pp. 65
    • Barazzuol, L.1    Jena, R.2    Burnet, N.G.3    Meira, L.B.4    Jeynes, J.C.5    Kirkby, K.J.6    Kirkby, N.F.7
  • 14
    • 79953054421 scopus 로고    scopus 로고
    • Strategies to improve radiotherapy with targeted drugs
    • Begg A.C., Stewart F.A., Vens C. Strategies to improve radiotherapy with targeted drugs. Nat. Rev. Cancer 2011, 11:239-253.
    • (2011) Nat. Rev. Cancer , vol.11 , pp. 239-253
    • Begg, A.C.1    Stewart, F.A.2    Vens, C.3
  • 16
    • 84922819486 scopus 로고    scopus 로고
    • High-affinity DNA-binding domains of replication protein A (RPA) direct SMARCAL1-dependent replication fork remodeling
    • Bhat K.P., Bétous R., Cortez D. High-affinity DNA-binding domains of replication protein A (RPA) direct SMARCAL1-dependent replication fork remodeling. J. Biol. Chem. 2015, 290:4110-4117.
    • (2015) J. Biol. Chem. , vol.290 , pp. 4110-4117
    • Bhat, K.P.1    Bétous, R.2    Cortez, D.3
  • 19
    • 84941805396 scopus 로고    scopus 로고
    • Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase
    • Buisson R., Boisvert J.L., Benes C.H., Zou L. Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase. Mol. Cell 2015, 59:1011-1024.
    • (2015) Mol. Cell , vol.59 , pp. 1011-1024
    • Buisson, R.1    Boisvert, J.L.2    Benes, C.H.3    Zou, L.4
  • 20
    • 18244371925 scopus 로고    scopus 로고
    • Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint
    • Byun T.S., Pacek M., Yee M.C., Walter J.C., Cimprich K.A. Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint. Genes Dev. 2005, 19:1040-1052.
    • (2005) Genes Dev. , vol.19 , pp. 1040-1052
    • Byun, T.S.1    Pacek, M.2    Yee, M.C.3    Walter, J.C.4    Cimprich, K.A.5
  • 21
    • 84908593807 scopus 로고    scopus 로고
    • DNA single-strand break repair
    • Caldecott K.W. DNA single-strand break repair. Exp. Cell Res. 2014, 329:2-8.
    • (2014) Exp. Cell Res. , vol.329 , pp. 2-8
    • Caldecott, K.W.1
  • 23
    • 84955360632 scopus 로고    scopus 로고
    • Repair Pathway Choices and Consequences at the Double-Strand Break
    • Ceccaldi R., Rondinelli B., D'Andrea A.D. Repair Pathway Choices and Consequences at the Double-Strand Break. Trends Cell Biol. 2015, 10.1016/j.tcb.2015.07.009.
    • (2015) Trends Cell Biol.
    • Ceccaldi, R.1    Rondinelli, B.2    D'Andrea, A.D.3
  • 24
    • 78649336706 scopus 로고    scopus 로고
    • The DNA damage response: making it safe to play with knives
    • Ciccia A., Elledge S.J. The DNA damage response: making it safe to play with knives. Mol. Cell 2010, 40:179-204.
    • (2010) Mol. Cell , vol.40 , pp. 179-204
    • Ciccia, A.1    Elledge, S.J.2
  • 25
    • 47749141560 scopus 로고    scopus 로고
    • ATR: an essential regulator of genome integrity
    • Cimprich K.A., Cortez D. ATR: an essential regulator of genome integrity. Nat. Rev. Mol. Cell Biol. 2008, 9:616-627.
    • (2008) Nat. Rev. Mol. Cell Biol. , vol.9 , pp. 616-627
    • Cimprich, K.A.1    Cortez, D.2
  • 27
    • 84870218588 scopus 로고    scopus 로고
    • DNA repair dysregulation from cancer driver to therapeutic target
    • Curtin N.J. DNA repair dysregulation from cancer driver to therapeutic target. Nat. Rev. Cancer 2012, 12:801-817.
    • (2012) Nat. Rev. Cancer , vol.12 , pp. 801-817
    • Curtin, N.J.1
  • 30
    • 84886644238 scopus 로고    scopus 로고
    • Wee1 kinase as a target for cancer therapy
    • Do K., Doroshow J.H., Kummar S. Wee1 kinase as a target for cancer therapy. Cell Cycle 2013, 12:3159-3164.
    • (2013) Cell Cycle , vol.12 , pp. 3159-3164
    • Do, K.1    Doroshow, J.H.2    Kummar, S.3
  • 32
    • 84921718845 scopus 로고    scopus 로고
    • Purification of proteins on newly synthesized DNA using iPOND
    • Dungrawala H., Cortez D. Purification of proteins on newly synthesized DNA using iPOND. Methods Mol. Biol. 2015, 1228:123-131.
    • (2015) Methods Mol. Biol. , vol.1228 , pp. 123-131
    • Dungrawala, H.1    Cortez, D.2
  • 33
    • 84941809696 scopus 로고    scopus 로고
    • The Replication Checkpoint Prevents Two Types of Fork Collapse without Regulating Replisome Stability
    • Dungrawala H., Rose K.L., Bhat K.P., Mohni K.N., Glick G.G., Couch F.B., Cortez D. The Replication Checkpoint Prevents Two Types of Fork Collapse without Regulating Replisome Stability. Mol. Cell 2015, 59:998-1010.
    • (2015) Mol. Cell , vol.59 , pp. 998-1010
    • Dungrawala, H.1    Rose, K.L.2    Bhat, K.P.3    Mohni, K.N.4    Glick, G.G.5    Couch, F.B.6    Cortez, D.7
  • 35
    • 84947795771 scopus 로고    scopus 로고
    • Lynparza recommended for approval in ovarian cancer
    • EMA (2014). Lynparza recommended for approval in ovarian cancer. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002196.jsp&mid=WC0b01ac058004d5c1.
    • (2014)
  • 37
    • 54949098894 scopus 로고    scopus 로고
    • Nucleoside analogs: molecular mechanisms signaling cell death
    • Ewald B., Sampath D., Plunkett W. Nucleoside analogs: molecular mechanisms signaling cell death. Oncogene 2008, 27:6522-6537.
    • (2008) Oncogene , vol.27 , pp. 6522-6537
    • Ewald, B.1    Sampath, D.2    Plunkett, W.3
  • 38
    • 33749134033 scopus 로고    scopus 로고
    • A dynamic model for replication protein A (RPA) function in DNA processing pathways
    • Fanning E., Klimovich V., Nager A.R. A dynamic model for replication protein A (RPA) function in DNA processing pathways. Nucleic Acids Res. 2006, 34:4126-4137.
    • (2006) Nucleic Acids Res. , vol.34 , pp. 4126-4137
    • Fanning, E.1    Klimovich, V.2    Nager, A.R.3
  • 40
    • 84947765804 scopus 로고    scopus 로고
    • FDA approves Lynparza to treat advanced ovarian cancer
    • FDA (2015). FDA approves Lynparza to treat advanced ovarian cancer. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427554.htm.
    • (2015)
  • 42
    • 77952105389 scopus 로고    scopus 로고
    • Inflammatory networks during cellular senescence: causes and consequences
    • Freund A., Orjalo A.V., Desprez P.Y., Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med. 2010, 16:238-246.
    • (2010) Trends Mol. Med. , vol.16 , pp. 238-246
    • Freund, A.1    Orjalo, A.V.2    Desprez, P.Y.3    Campisi, J.4
  • 47
    • 40449120350 scopus 로고    scopus 로고
    • An oncogene-induced DNA damage model for cancer development
    • Halazonetis T.D., Gorgoulis V.G., Bartek J. An oncogene-induced DNA damage model for cancer development. Science 2008, 319:1352-1355.
    • (2008) Science , vol.319 , pp. 1352-1355
    • Halazonetis, T.D.1    Gorgoulis, V.G.2    Bartek, J.3
  • 49
    • 0030667434 scopus 로고    scopus 로고
    • Integrating genetic approaches into the discovery of anticancer drugs
    • Hartwell L.H., Szankasi P., Roberts C.J., Murray A.W., Friend S.H. Integrating genetic approaches into the discovery of anticancer drugs. Science 1997, 278:1064-1068.
    • (1997) Science , vol.278 , pp. 1064-1068
    • Hartwell, L.H.1    Szankasi, P.2    Roberts, C.J.3    Murray, A.W.4    Friend, S.H.5
  • 50
    • 80052168685 scopus 로고    scopus 로고
    • The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings
    • Helleday T. The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings. Mol. Oncol. 2011, 5:387-393.
    • (2011) Mol. Oncol. , vol.5 , pp. 387-393
    • Helleday, T.1
  • 51
    • 31844456472 scopus 로고    scopus 로고
    • Replication fork reactivation downstream of a blocked nascent leading strand
    • Heller R.C., Marians K.J. Replication fork reactivation downstream of a blocked nascent leading strand. Nature 2006, 439:557-562.
    • (2006) Nature , vol.439 , pp. 557-562
    • Heller, R.C.1    Marians, K.J.2
  • 54
    • 0035902108 scopus 로고    scopus 로고
    • Genome maintenance mechanisms for preventing cancer
    • Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 2001, 411:366-374.
    • (2001) Nature , vol.411 , pp. 366-374
    • Hoeijmakers, J.H.1
  • 55
    • 70349859881 scopus 로고    scopus 로고
    • DNA damage, aging, and cancer
    • Hoeijmakers J.H. DNA damage, aging, and cancer. N. Engl. J. Med. 2009, 361:1475-1485.
    • (2009) N. Engl. J. Med. , vol.361 , pp. 1475-1485
    • Hoeijmakers, J.H.1
  • 56
    • 70350504453 scopus 로고    scopus 로고
    • The DNA-damage response in human biology and disease
    • Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature 2009, 461:1071-1078.
    • (2009) Nature , vol.461 , pp. 1071-1078
    • Jackson, S.P.1    Bartek, J.2
  • 57
    • 33646187811 scopus 로고    scopus 로고
    • The multifaceted mismatch-repair system
    • Jiricny J. The multifaceted mismatch-repair system. Nat. Rev. Mol. Cell Biol. 2006, 7:335-346.
    • (2006) Nat. Rev. Mol. Cell Biol. , vol.7 , pp. 335-346
    • Jiricny, J.1
  • 58
    • 84881480253 scopus 로고    scopus 로고
    • Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress
    • Jones R.M., Mortusewicz O., Afzal I., Lorvellec M., García P., Helleday T., Petermann E. Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress. Oncogene 2013, 32:3744-3753.
    • (2013) Oncogene , vol.32 , pp. 3744-3753
    • Jones, R.M.1    Mortusewicz, O.2    Afzal, I.3    Lorvellec, M.4    García, P.5    Helleday, T.6    Petermann, E.7
  • 59
    • 84917706821 scopus 로고    scopus 로고
    • ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses
    • Jossé R., Martin S.E., Guha R., Ormanoglu P., Pfister T.D., Reaper P.M., Barnes C.S., Jones J., Charlton P., Pollard J.R., et al. ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses. Cancer Res. 2014, 74:6968-6979.
    • (2014) Cancer Res. , vol.74 , pp. 6968-6979
    • Jossé, R.1    Martin, S.E.2    Guha, R.3    Ormanoglu, P.4    Pfister, T.D.5    Reaper, P.M.6    Barnes, C.S.7    Jones, J.8    Charlton, P.9    Pollard, J.R.10
  • 60
    • 34249900982 scopus 로고    scopus 로고
    • Direct cellular responses to platinum-induced DNA damage
    • Jung Y., Lippard S.J. Direct cellular responses to platinum-induced DNA damage. Chem. Rev. 2007, 107:1387-1407.
    • (2007) Chem. Rev. , vol.107 , pp. 1387-1407
    • Jung, Y.1    Lippard, S.J.2
  • 61
    • 25444497278 scopus 로고    scopus 로고
    • The concept of synthetic lethality in the context of anticancer therapy
    • Kaelin W.G. The concept of synthetic lethality in the context of anticancer therapy. Nat. Rev. Cancer 2005, 5:689-698.
    • (2005) Nat. Rev. Cancer , vol.5 , pp. 689-698
    • Kaelin, W.G.1
  • 63
    • 77955889790 scopus 로고    scopus 로고
    • Expanded roles of the Fanconi anemia pathway in preserving genomic stability
    • Kee Y., D'Andrea A.D. Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev. 2010, 24:1680-1694.
    • (2010) Genes Dev. , vol.24 , pp. 1680-1694
    • Kee, Y.1    D'Andrea, A.D.2
  • 65
    • 84919361106 scopus 로고    scopus 로고
    • Replication stress and cancer: it takes two to tango
    • Lecona E., Fernández-Capetillo O. Replication stress and cancer: it takes two to tango. Exp. Cell Res. 2014, 329:26-34.
    • (2014) Exp. Cell Res. , vol.329 , pp. 26-34
    • Lecona, E.1    Fernández-Capetillo, O.2
  • 67
    • 84903547236 scopus 로고    scopus 로고
    • Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
    • Ledermann J., Harter P., Gourley C., Friedlander M., Vergote I., Rustin G., Scott C.L., Meier W., Shapira-Frommer R., Safra T., et al. Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Lancet Oncol. 2014, 15:852-861.
    • (2014) Lancet Oncol. , vol.15 , pp. 852-861
    • Ledermann, J.1    Harter, P.2    Gourley, C.3    Friedlander, M.4    Vergote, I.5    Rustin, G.6    Scott, C.L.7    Meier, W.8    Shapira-Frommer, R.9    Safra, T.10
  • 68
    • 85007146303 scopus 로고    scopus 로고
    • Phase II study with Wee1 inhibitor AZD1775 plus carboplatin in patients with p53 mutated ovarian cancer refractory or resistant (<3 months) to standard first line therapy
    • Leijen S., van Geel R., Sonke G.S., de Jong D., Rosenberg E.H., Marchetti S., Pluim D., van Werkhoven E.D., Rose S., Lee M.A., et al. Phase II study with Wee1 inhibitor AZD1775 plus carboplatin in patients with p53 mutated ovarian cancer refractory or resistant (<3 months) to standard first line therapy. J. Clin. Oncol. 2015, 33. abstr2507.
    • (2015) J. Clin. Oncol. , vol.33
    • Leijen, S.1    van Geel, R.2    Sonke, G.S.3    de Jong, D.4    Rosenberg, E.H.5    Marchetti, S.6    Pluim, D.7    van Werkhoven, E.D.8    Rose, S.9    Lee, M.A.10
  • 69
    • 77953229115 scopus 로고    scopus 로고
    • The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway
    • Lieber M.R. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu. Rev. Biochem. 2010, 79:181-211.
    • (2010) Annu. Rev. Biochem. , vol.79 , pp. 181-211
    • Lieber, M.R.1
  • 70
    • 0028865245 scopus 로고
    • Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks
    • Lindahl T., Satoh M.S., Poirier G.G., Klungland A. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem. Sci. 1995, 20:405-411.
    • (1995) Trends Biochem. Sci. , vol.20 , pp. 405-411
    • Lindahl, T.1    Satoh, M.S.2    Poirier, G.G.3    Klungland, A.4
  • 71
    • 84908134454 scopus 로고    scopus 로고
    • Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
    • Liu J.F., Barry W.T., Birrer M., Lee J.M., Buckanovich R.J., Fleming G.F., Rimel B., Buss M.K., Nattam S., Hurteau J., et al. Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study. Lancet Oncol. 2014, 15:1207-1214.
    • (2014) Lancet Oncol. , vol.15 , pp. 1207-1214
    • Liu, J.F.1    Barry, W.T.2    Birrer, M.3    Lee, J.M.4    Buckanovich, R.J.5    Fleming, G.F.6    Rimel, B.7    Buss, M.K.8    Nattam, S.9    Hurteau, J.10
  • 72
    • 84856019858 scopus 로고    scopus 로고
    • The DNA damage response and cancer therapy
    • Lord C.J., Ashworth A. The DNA damage response and cancer therapy. Nature 2012, 481:287-294.
    • (2012) Nature , vol.481 , pp. 287-294
    • Lord, C.J.1    Ashworth, A.2
  • 73
    • 0014285011 scopus 로고
    • Synthetic lethality and semi-lethality among functionally related mutants of Drosophila melanfgaster
    • Lucchesi J.C. Synthetic lethality and semi-lethality among functionally related mutants of Drosophila melanfgaster. Genetics 1968, 59:37-44.
    • (1968) Genetics , vol.59 , pp. 37-44
    • Lucchesi, J.C.1
  • 75
    • 84921932554 scopus 로고    scopus 로고
    • DNA replication stress as a hallmark of cancer
    • Macheret M., Halazonetis T.D. DNA replication stress as a hallmark of cancer. Annu. Rev. Pathol. 2015, 10:425-448.
    • (2015) Annu. Rev. Pathol. , vol.10 , pp. 425-448
    • Macheret, M.1    Halazonetis, T.D.2
  • 76
    • 77953658106 scopus 로고    scopus 로고
    • Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2
    • Martin S.A., McCarthy A., Barber L.J., Burgess D.J., Parry S., Lord C.J., Ashworth A. Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2. EMBO Mol. Med. 2009, 1:323-337.
    • (2009) EMBO Mol. Med. , vol.1 , pp. 323-337
    • Martin, S.A.1    McCarthy, A.2    Barber, L.J.3    Burgess, D.J.4    Parry, S.5    Lord, C.J.6    Ashworth, A.7
  • 78
    • 34250010317 scopus 로고    scopus 로고
    • Chk1 regulates the density of active replication origins during the vertebrate S phase
    • Maya-Mendoza A., Petermann E., Gillespie D.A., Caldecott K.W., Jackson D.A. Chk1 regulates the density of active replication origins during the vertebrate S phase. EMBO J. 2007, 26:2719-2731.
    • (2007) EMBO J. , vol.26 , pp. 2719-2731
    • Maya-Mendoza, A.1    Petermann, E.2    Gillespie, D.A.3    Caldecott, K.W.4    Jackson, D.A.5
  • 80
    • 77649131406 scopus 로고    scopus 로고
    • Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis
    • Moynahan M.E., Jasin M. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat. Rev. Mol. Cell Biol. 2010, 11:196-207.
    • (2010) Nat. Rev. Mol. Cell Biol. , vol.11 , pp. 196-207
    • Moynahan, M.E.1    Jasin, M.2
  • 82
    • 84901218339 scopus 로고    scopus 로고
    • Rationale for poly(ADP-ribose) polymerase (PARP) inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibition
    • Murai J., Zhang Y., Morris J., Ji J., Takeda S., Doroshow J.H., Pommier Y. Rationale for poly(ADP-ribose) polymerase (PARP) inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibition. J. Pharmacol. Exp. Ther. 2014, 349:408-416.
    • (2014) J. Pharmacol. Exp. Ther. , vol.349 , pp. 408-416
    • Murai, J.1    Zhang, Y.2    Morris, J.3    Ji, J.4    Takeda, S.5    Doroshow, J.H.6    Pommier, Y.7
  • 83
    • 36949012288 scopus 로고    scopus 로고
    • Targeted cancer therapies based on the inhibition of DNA strand break repair
    • O'Connor M.J., Martin N.M., Smith G.C. Targeted cancer therapies based on the inhibition of DNA strand break repair. Oncogene 2007, 26:7816-7824.
    • (2007) Oncogene , vol.26 , pp. 7816-7824
    • O'Connor, M.J.1    Martin, N.M.2    Smith, G.C.3
  • 84
    • 84947779778 scopus 로고    scopus 로고
    • Generating preclinical models to assess bone marrow toxicity induced by the PARP inhibitor olaparib in combination with chemotherapy
    • O'Connor M.J., Mason H., Horner S., Slater I., Lau A., Cadogan E., Oplustilova L. Generating preclinical models to assess bone marrow toxicity induced by the PARP inhibitor olaparib in combination with chemotherapy. Cancer Res. 2013, 73. 10.1158/1538-7445.AM2013-4420.
    • (2013) Cancer Res. , vol.73
    • O'Connor, M.J.1    Mason, H.2    Horner, S.3    Slater, I.4    Lau, A.5    Cadogan, E.6    Oplustilova, L.7
  • 86
    • 79952747328 scopus 로고    scopus 로고
    • Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells
    • Patel A.G., Sarkaria J.N., Kaufmann S.H. Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells. Proc. Natl. Acad. Sci. USA 2011, 108:3406-3411.
    • (2011) Proc. Natl. Acad. Sci. USA , vol.108 , pp. 3406-3411
    • Patel, A.G.1    Sarkaria, J.N.2    Kaufmann, S.H.3
  • 88
    • 84906899772 scopus 로고    scopus 로고
    • RADical response puts an exceptional responder in CHKmate: a synthetic lethal curative response to DNA-damaging chemotherapy?
    • Peng G., Woodman S.E., Mills G.B. RADical response puts an exceptional responder in CHKmate: a synthetic lethal curative response to DNA-damaging chemotherapy?. Cancer Discov. 2014, 4:988-990.
    • (2014) Cancer Discov. , vol.4 , pp. 988-990
    • Peng, G.1    Woodman, S.E.2    Mills, G.B.3
  • 89
    • 77957982422 scopus 로고    scopus 로고
    • Chk1 promotes replication fork progression by controlling replication initiation
    • Petermann E., Woodcock M., Helleday T. Chk1 promotes replication fork progression by controlling replication initiation. Proc. Natl. Acad. Sci. USA 2010, 107:16090-16095.
    • (2010) Proc. Natl. Acad. Sci. USA , vol.107 , pp. 16090-16095
    • Petermann, E.1    Woodcock, M.2    Helleday, T.3
  • 90
    • 59449085305 scopus 로고    scopus 로고
    • Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors
    • Plummer R., Jones C., Middleton M., Wilson R., Evans J., Olsen A., Curtin N., Boddy A., McHugh P., Newell D., et al. Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors. Clin. Cancer Res. 2008, 14:7917-7923.
    • (2008) Clin. Cancer Res. , vol.14 , pp. 7917-7923
    • Plummer, R.1    Jones, C.2    Middleton, M.3    Wilson, R.4    Evans, J.5    Olsen, A.6    Curtin, N.7    Boddy, A.8    McHugh, P.9    Newell, D.10
  • 91
    • 77954187741 scopus 로고    scopus 로고
    • DNA topoisomerases and their poisoning by anticancer and antibacterial drugs
    • Pommier Y., Leo E., Zhang H., Marchand C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem. Biol. 2010, 17:421-433.
    • (2010) Chem. Biol. , vol.17 , pp. 421-433
    • Pommier, Y.1    Leo, E.2    Zhang, H.3    Marchand, C.4
  • 92
    • 84926432359 scopus 로고    scopus 로고
    • Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins
    • Prakash R., Zhang Y., Feng W., Jasin M. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Cold Spring Harb. Perspect. Biol. 2015, 7:a016600.
    • (2015) Cold Spring Harb. Perspect. Biol. , vol.7 , pp. a016600
    • Prakash, R.1    Zhang, Y.2    Feng, W.3    Jasin, M.4
  • 93
    • 84900410570 scopus 로고    scopus 로고
    • Non-homologous end joining: emerging themes and unanswered questions
    • Radhakrishnan S.K., Jette N., Lees-Miller S.P. Non-homologous end joining: emerging themes and unanswered questions. DNA Repair (Amst.) 2014, 17:2-8.
    • (2014) DNA Repair (Amst.) , vol.17 , pp. 2-8
    • Radhakrishnan, S.K.1    Jette, N.2    Lees-Miller, S.P.3
  • 97
    • 84899035081 scopus 로고    scopus 로고
    • Myc induced replicative stress response: How to cope with it and exploit it
    • Rohban S., Campaner S. Myc induced replicative stress response: How to cope with it and exploit it. Biochim. Biophys. Acta 2015, 1849:517-524.
    • (2015) Biochim. Biophys. Acta , vol.1849 , pp. 517-524
    • Rohban, S.1    Campaner, S.2
  • 98
    • 0037884963 scopus 로고    scopus 로고
    • Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses
    • Rothkamm K., Löbrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc. Natl. Acad. Sci. USA 2003, 100:5057-5062.
    • (2003) Proc. Natl. Acad. Sci. USA , vol.100 , pp. 5057-5062
    • Rothkamm, K.1    Löbrich, M.2
  • 99
    • 84908213474 scopus 로고    scopus 로고
    • Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
    • Sabharwal S.S., Schumacker P.T. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?. Nat. Rev. Cancer 2014, 14:709-721.
    • (2014) Nat. Rev. Cancer , vol.14 , pp. 709-721
    • Sabharwal, S.S.1    Schumacker, P.T.2
  • 100
    • 84866564290 scopus 로고    scopus 로고
    • Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study
    • Samol J., Ranson M., Scott E., Macpherson E., Carmichael J., Thomas A., Cassidy J. Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study. Invest. New Drugs 2012, 30:1493-1500.
    • (2012) Invest. New Drugs , vol.30 , pp. 1493-1500
    • Samol, J.1    Ranson, M.2    Scott, E.3    Macpherson, E.4    Carmichael, J.5    Thomas, A.6    Cassidy, J.7
  • 101
    • 83355174034 scopus 로고    scopus 로고
    • Targeting radiation-induced G(2) checkpoint activation with the Wee-1 inhibitor MK-1775 in glioblastoma cell lines
    • Sarcar B., Kahali S., Prabhu A.H., Shumway S.D., Xu Y., Demuth T., Chinnaiyan P. Targeting radiation-induced G(2) checkpoint activation with the Wee-1 inhibitor MK-1775 in glioblastoma cell lines. Mol. Cancer Ther. 2011, 10:2405-2414.
    • (2011) Mol. Cancer Ther. , vol.10 , pp. 2405-2414
    • Sarcar, B.1    Kahali, S.2    Prabhu, A.H.3    Shumway, S.D.4    Xu, Y.5    Demuth, T.6    Chinnaiyan, P.7
  • 104
    • 3242670803 scopus 로고    scopus 로고
    • ATR and ATM regulate the timing of DNA replication origin firing
    • Shechter D., Costanzo V., Gautier J. ATR and ATM regulate the timing of DNA replication origin firing. Nat. Cell Biol. 2004, 6:648-655.
    • (2004) Nat. Cell Biol. , vol.6 , pp. 648-655
    • Shechter, D.1    Costanzo, V.2    Gautier, J.3
  • 105
    • 84898035920 scopus 로고    scopus 로고
    • DNA double-strand break repair in a cellular context
    • Shibata A., Jeggo P.A. DNA double-strand break repair in a cellular context. Clin. Oncol. (R Coll Radiol) 2014, 26:243-249.
    • (2014) Clin. Oncol. (R Coll Radiol) , vol.26 , pp. 243-249
    • Shibata, A.1    Jeggo, P.A.2
  • 106
    • 0011511768 scopus 로고    scopus 로고
    • Mechanisms of action of cancer chemotherapeutic agents: DNA-interactive alkylating agents and antitumour platinum-based drugs
    • John Wiley and Sons, Ltd. M.R. Alison (Ed.)
    • Siddik Z.H. Mechanisms of action of cancer chemotherapeutic agents: DNA-interactive alkylating agents and antitumour platinum-based drugs. The Cancer Handbook 2002, John Wiley and Sons, Ltd. M.R. Alison (Ed.).
    • (2002) The Cancer Handbook
    • Siddik, Z.H.1
  • 110
    • 77955019276 scopus 로고    scopus 로고
    • Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
    • Tutt A., Robson M., Garber J.E., Domchek S.M., Audeh M.W., Weitzel J.N., Friedlander M., Arun B., Loman N., Schmutzler R.K., et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet 2010, 376:235-244.
    • (2010) Lancet , vol.376 , pp. 235-244
    • Tutt, A.1    Robson, M.2    Garber, J.E.3    Domchek, S.M.4    Audeh, M.W.5    Weitzel, J.N.6    Friedlander, M.7    Arun, B.8    Loman, N.9    Schmutzler, R.K.10
  • 112
    • 0036285034 scopus 로고    scopus 로고
    • C-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability
    • Vafa O., Wade M., Kern S., Beeche M., Pandita T.K., Hampton G.M., Wahl G.M. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol. Cell 2002, 9:1031-1044.
    • (2002) Mol. Cell , vol.9 , pp. 1031-1044
    • Vafa, O.1    Wade, M.2    Kern, S.3    Beeche, M.4    Pandita, T.K.5    Hampton, G.M.6    Wahl, G.M.7
  • 113
    • 84896940791 scopus 로고    scopus 로고
    • Cancer suppression by the chromosome custodians, BRCA1 and BRCA2
    • Venkitaraman A.R. Cancer suppression by the chromosome custodians, BRCA1 and BRCA2. Science 2014, 343:1470-1475.
    • (2014) Science , vol.343 , pp. 1470-1475
    • Venkitaraman, A.R.1
  • 114
  • 115
    • 0002747511 scopus 로고    scopus 로고
    • Nature of lesions formed by ionizing radiation
    • Humana Press, J.A. Nickoloff, M.F. Hoekstra (Eds.)
    • Ward J.F. Nature of lesions formed by ionizing radiation. DNA Damage and Repair 1998, 265-284. Humana Press. J.A. Nickoloff, M.F. Hoekstra (Eds.).
    • (1998) DNA Damage and Repair , pp. 265-284
    • Ward, J.F.1
  • 117
    • 84880917692 scopus 로고    scopus 로고
    • First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
    • Weiss G.J., Chao J., Neidhart J.D., Ramanathan R.K., Bassett D., Neidhart J.A., Choi C.H., Chow W., Chung V., Forman S.J., et al. First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies. Invest. New Drugs 2013, 31:986-1000.
    • (2013) Invest. New Drugs , vol.31 , pp. 986-1000
    • Weiss, G.J.1    Chao, J.2    Neidhart, J.D.3    Ramanathan, R.K.4    Bassett, D.5    Neidhart, J.A.6    Choi, C.H.7    Chow, W.8    Chung, V.9    Forman, S.J.10
  • 121
    • 79953839433 scopus 로고    scopus 로고
    • CRLX101 (formerly IT-101)-A Novel Nanopharmaceutical of Camptothecin in Clinical Development
    • Young C., Schluep T., Hwang J., Eliasof S. CRLX101 (formerly IT-101)-A Novel Nanopharmaceutical of Camptothecin in Clinical Development. Curr. Bioact. Compd. 2011, 7:8-14.
    • (2011) Curr. Bioact. Compd. , vol.7 , pp. 8-14
    • Young, C.1    Schluep, T.2    Hwang, J.3    Eliasof, S.4
  • 122
    • 84891301320 scopus 로고    scopus 로고
    • Causes and consequences of replication stress
    • Zeman M.K., Cimprich K.A. Causes and consequences of replication stress. Nat. Cell Biol. 2014, 16:2-9.
    • (2014) Nat. Cell Biol. , vol.16 , pp. 2-9
    • Zeman, M.K.1    Cimprich, K.A.2
  • 123
    • 0037567268 scopus 로고    scopus 로고
    • Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes
    • Zou L., Elledge S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 2003, 300:1542-1548.
    • (2003) Science , vol.300 , pp. 1542-1548
    • Zou, L.1    Elledge, S.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.